---
figid: PMC10239578__12905_2023_2420_Fig4_HTML
pmcid: PMC10239578
image_filename: 12905_2023_2420_Fig4_HTML.jpg
figure_link: /pmc/articles/PMC10239578/figure/Fig3/
number: Fig. 3
figure_title: ''
caption: (A) Distribution of the 32 DEGs at the gene set level. (B) Genes differentially
  expressed between the PR and PS involved in two or all the PI3K, MAPK, and Cell
  Cycle-Apoptosis pathways. NGF, nerve growth factor; AKT3, v-akt murine thymoma viral
  oncogene homolog 3; CCND2, cyclin D2; PDGFRA, platelet-derived growth factor receptor,
  alpha polypeptide; CCND1, cyclin D1; CCND3, cyclin D3; FGF9, fibroblast growth factor
  9; FGF11, fibroblast growth factor 11
article_title: Differential molecular pathway expression according to chemotherapeutic
  response in ovarian clear cell carcinoma.
citation: Min Yin, et al. BMC Womens Health. 2023;23:298.
year: '2023'

doi: 10.1186/s12905-023-02420-1
journal_title: BMC Women's Health
journal_nlm_ta: BMC Womens Health
publisher_name: BioMed Central

keywords:
- Ovarian clear cell carcinoma
- Gene expression profiling
- Drug resistance
- Platinum

---
